5 WALNUT GROVE DRIVE, HORSHAM, PA
STRATA Skin Sciences Enters $11 Million Equity Distribution Agreement
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces Closing of $2.42 Million Registered Direct Offering
Announces Pricing of $2.42 Million Registered Direct Offering of Common Stock Priced At-Market Under Nasdaq Rules
Investor Presentation
Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients
Q2
Q1
Amended Annual Report
FY 2024
Q3
FY 2023 amended
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
PRE 14A
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Correspondence
Submission Upload